Release and functional role of neuropeptide Y as a sympathetic modulator in human saphenous vein biopsies

Peptides

Volumn 25, Issue 1, 2004, Pages 53-64

  Donoso, M V ^a   Miranda, R ^a   Briones, R ^a   Irarrazaval M J ^b   Huidobro Toro, J Pablo ^a  

^a P Universidad Católica de Chile   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

HNPY release; Human vascular biopsies; NPY neuromodulation; Oxidized NPY; Saphenous vein biopsies; Sympathetic co transmission; Vascular reflexes

Indexed keywords

CALCIUM; GUANETHIDINE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NORADRENALIN; PHENOXYBENZAMINE;

ARTICLE; BLOOD VESSEL BIOPSY; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG POTENTIATION; ELECTROSTIMULATION; EXTRACELLULAR CALCIUM; GENETIC CODE; HUMAN; HUMAN TISSUE; NERVE ENDING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; SYMPATHETIC NERVE; SYMPATHETIC TONE; VENOCONSTRICTION;

ADENOSINE TRIPHOSPHATE; AGED; CALCIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; GUANETHIDINE; HUMANS; MALE; MIDDLE AGED; NEUROPEPTIDE Y; PHENOXYBENZAMINE; SAPHENOUS VEIN; SYNAPTIC TRANSMISSION; VASOCONSTRICTION;

EID: 1542315475     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.11.001     Document Type: Article

References (55)

1. Ahlborg G., Weitzberg E., Sollevi A., Lundberg J.M. Splanic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man. Acta. Physiol. Scand. 145:1992;139-149.
2. Bartfai T. Presynaptic aspects of the coexistence of classical neurotransmitters and peptides. Trends Pharmacol. Sci. 6:1985;331-334.
3. Bergdahl A., Nilsson T., Cantera L., Nilsson L., Sun X.Y., Hedner T.et al. Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor. Eur. J. Pharmacol. 316:1996;59-64.
4. 2 receptors. Eur. J. Pharmacol. 294:1995;391-401.
5. Brock J.A., Cunnane T.C. Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerves. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;504-509.
6. 1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304. Eur. J. Pharmacol. 376:1999;251-255.
7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
8. Ciorba M.A., Heinemann S.H., Weissbach H., Brot N., Hosh T. Modulation of potassium channel function by methionine oxidation and reduction. Proc. Natl. Acad. Sci. USA. 94:1997;9932-9937.
9. Corder R., Emson P.C., Lowry P.J. Purification and characterization of human neuropeptide Y from adrenal-medullary phaeochromocytoma tissue. Biochem. J. 219:1984;699-706.
10. Cubeddu L., Barnes E.M., Langer Z., Weiner N. Release of norepinephrine and dopamine-β-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors. J. Pharmacol. Exp. Ther. 190:1974;431-450.
11. De Potter W.P., Kurzawa R., Miserez B., Coen E.P. Evidence against differential release of noradrenaline, neuropeptide Y, and dopamine-beta- hydroxylase from adrenergic nerves in the isolated perfused sheep spleen. Synapse. 19:1995;67-76.
12. 1 receptor antagonist BIBP 3226. J. Pharmacol. Exp. Ther. 275:1995;136-142.
13. Donoso M.V., Brown N., Carrasco C., Cortes V., Fournier A., Huidobro-Toro J.P. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiate the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors. J. Neurochem. 69:1997;1048-1059.
14. 2-Adrenoceptors control the release of noradrenaline but not neuropeptide Y from perivascular nerve terminals. Peptides. 23:2002;1663-1671.
15. Donoso M.V., Huidobro-Toro J.P. A2-adenosine presynaptic receptors modulates the release of noradrenaline (NE) but not neuropeptide Y (NPY). J. Neurochem. 78:2001;160.
16. Donoso M.V., Silva M., St. Pierre S., Huidobro-Toro J.P. Neuropeptide Y (NPY), an endogenous presynaptic modulator of adrenergic neurotransmission in the rat vas deferens: structural and functional studies. Peptides. 9:1988;545-552.
17. Edvinsson L. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries. Acta. Physiol. Scand. 125:1985;33-41.
18. Edvinsson L., Ekblad E., Håkanson R., Wahlestedt K. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br. J. Pharmacol. 83:1984;519-525.
19. Erlinge D., Ekman R., Thulin T., Edvinsson L. Neuropeptide Y-like immunoreactivity and hypertension. J. Hypertens. 10:1992;1221-1225.
20. Eurin J., Barthélemy C., Masson F., Maistre G., Soualmia H., Noé E.et al. Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas. Regul. Peptides. 86:2000;95-102.
21. Feng Q., Lambert M.L., Callow I.D., Arnold J.M. Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure. Clin. Pharmacol. Ther. 67:2000;292-298.
22. 2 receptors by substituted and truncated neuropeptide y analogs: identification of signal epitopes. Eur. J. Pharmacol. 232:1992;271-278.
23. Hegbrant J., Thysell H., Ekman R. Circulating neuropeptide Y in plasma from uremic patients consists of multiple peptide fragments. Peptides. 16:1995;395-397.
24. Hunter L.W., Tyce G.M., Rorie D.K. Neuropeptide Y release and contractile properties: differences between canine veins and arteries. Eur. J. Pharmacol. 313:1996;79-87.
25. Kaijser L., Pernow J., Berglund B., Grunnstrom J., Lundberg J.M. Neuropeptide Y release form human heart is enhanced during prolonged exercise in hipoxia. J. Appl. Physiol. 76:1994;1346-1349.
26. Khatun S., Kanayama N., Belayet H.M., Bhuiyan A.B., Jahan S., Begum A.et al. Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia. Am. J. Obstet. Gynecol. 182:2000;896-900.
27. López L.F., Perez A., St-Pierre S., Huidobro-Toro J.P. Neuropeptide tyrosine (NPY)-induced potentiation of the pressor activity of catecholamines in conscious rats. Peptides. 10:1989;551-558.
28. Lundberg J.M., Rudehill A., Sollevi A., fried G., Wallin G. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience. 28:1989;475-486.
29. Lundberg J.M., Rudehill A., Sollevi A., Hamberger B. Evidence for co-transmitter role of neuropeptide Y in the pig spleen. Br. J. Pharmacol. 96:1989;675-687.
30. Lundberg J.M., Rudehill A., Sollevi A., Theodorsson-Norheim E., Hamberger B. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci. Lett. 63:1986;96-100.
31. Macho P., Pérez R., Huidobro-Toro J.P., Domenech R. Neuropeptide Y: a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction. Eur. J. Pharmacol. 167:1989;67-74.
32. McCarthy J.B., Walker M., Pierce J., Camp P., White J.D. Biosynthesis and metabolism of native and oxidized neuropeptide Y in the hippocampal mossy fiber system. J. Neurochem. 70:1998;1950-1963.
33. Mezzano V., Donoso M.V., Capurro D., Huidobro-Toro J.P. Increased neuropeptide Y pressor activity in Goldblatt hypertensive rats: in vivo studies with BIBP 3226. Peptides. 19:1998;1227-1232.
34. Moskovitz J., Jenkins N.A., Gilbert D.J., Copeland N.G., Jursky F., Weissbach H. Brot, N, chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc. Natl. Acad. Sci. USA. 93:1996a;3205-3208.
35. Moskovitz J., Weissbach H., Brot N. Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc. Natl. Acad. Sci. USA. 93:1996;2095-2099.
36. Nilsson T., You J., Sun X., Hedner T., Edvinsson L. Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation. Blood Press. 5:1996;164-169.
37. O'Hare M.M.T., Schwartz T. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors. Cancer Res. 49:1989;7010-7014.
38. Omland T., Opstad P.K., Dickenstein K. Plasma neuropeptide Y levels in the acute and early convalescent phase after myocardial infarction. Am. Heart J. 127:1994;774-779.
39. Przywara D.A., Chowdhury P.S., Bhave S.V., Wakade T.D., Wakade A.R. Barium-induced exocytosis is due to internal calcium release and block of calcium efflux. Proc. Natl. Acad. Sci. USA. 90:1993;557-561.
40. Racchi H., Irarrázabal M.J., Howard M., Morán S., Zalaquett R., Huidobro-Toro J.P. Adenosine 5′-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein. Br. J. Pharmacol. 126:1999;1175-1185.
41. Rahman M.A., Nelson H., Weissbach H., Brot N. Cloning, sequencing, and expression of the Escherichia coli peptide methionine sulfoxide reductase gene. J. Biol. Chem. 267:1992;15549-15551.
42. Rump L.C., Von Kugelgen I. A study of ATP as a sympathetic cotransmitter in human saphenous vein. Br. J. Pharmacol. 111:1994;65-72.
43. 1 receptor. Mol. Pharmacol. 50:1996;285-292.
44. Stenfors C., Mathé A.A., Theodorsson E. Chromatographic and immunochemical characterization of rat brain neuropeptide Y-like immunoreactivity (NPY-LI) following repeated electroconvulsive stimuli. J. Neurosci. Res. 41:1995;206-212.
45. Souza V., Bucio L., Jay D., Chavez E., Gutierrez-Ruiz M.C. Effect of cadmium on calcium transport in a human fetal hepatic cell line (WRL-68 cells). Toxicology. 112:1996;97-104.
46. Tabarin A., Cassiède P., Minot A.P., Cuber J.C., Roger P., Ducassou D. Heterogeneity of neuropeptide Y immunoreactivty in patients with pheochromocytoma: influence on the diagnostic power of measuring plasma NPY using antisera with different specificities. Acta Endocrinol. 128:1993;243-250.
47. Tajti J., Moller S., Uddman R., Bodi I., Edvinsson L. The human superior cervical ganglion: neuropeptides and peptide receptors. Neurosci. Lett. 263:1999;121-124.
48. Takiyyuddin M.A., Brown M.R., Dinh T.Q., Cervenka J.H., Braun S.D., Parmer R.J.et al. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. J. Auton. Pharmacol. 14:1994;187-200.
49. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA. 79:1982;5485-5489.
50. Uddman R., Moller S., Nilsson T., Nystrom S., Ekstrand J., Edvinsson L. Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues. Peptides. 23:2002;927-934.
51. Valenzuela R.F., Donoso M.V., Mellado P., Huidobro-Toro J.P. Migraine, but not subarachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF. J. Neurol. Sci. 173:2000;140-146.
52. 2. Ann. N.Y. Acad. Sci. 611:1990;7-26.
53. You J., Edvinsson L., Bryan R.M. Jr. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries. J. Cereb. Blood Flow Metab. 21:2001;77-84.
54. Zucker R.S. Exocytosis: a molecular and physiological perspective. Neuron. 17:1996;1049-1055.
55. Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann. N.Y. Acad. Sci. 29(771):1995;219-233.